Molecular Templates, Inc., a clinical stage oncology company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. The company primarily develops a pipeline of engineered toxin bodies. Its lead drug candidate is MT-3724 that is in a Phase II clinical trial for the treatment of relapsed/refractory diffuse large B-cell lymphoma; and Phase II clinical trial for treating non-Hodgkin's lymphoma. The company also develops MT-4019, engineered toxin body targeting CD38; and TAK-169 targeting CD38. It has an agreement with Takeda Pharmaceutical Company Limited to develop CD38-targeted engineered toxin bodies for the treatment of patients with diseases, such as multiple myeloma; and a strategic research collaboration with Vertex Pharmaceuticals Incorporated to discover and develop novel targeted conditioning regimens to enhance the hematopoietic stem cell transplant process. Molecular Templates, Inc. is headquartered in Austin, Texas.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [11/22/2019 10:10 PST] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($8.11) From $8.110 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [11/21/2019 21:16 PST] Market Maker Surveillance Report. MTEM, Winning Stocks With Lowest Price Friction For Thursday, November 21st 2019
• [11/21/2019 09:51 PST] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($7.46) After BUYINS.NET SqueezeTrigger Report Released on Friday, November 15th 2019 at a Price of $7.460.
• [11/20/2019 07:39 PST] MTEM Expected to Trade Up Short Term
• [11/15/2019 10:10 PST] MTEM SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [10/23/2019 10:10 PDT] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($7.04) From $7.040 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/22/2019 12:42 PDT] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($6.80) From $6.800 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/22/2019 09:51 PDT] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($7.86) From $7.860 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/21/2019 11:07 PDT] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($6.97) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, October 15th 2019 at a Price of $6.970.
• [10/21/2019 11:07 PDT] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($6.97) After BUYINS.NET SqueezeTrigger Report Released on Friday, October 11th 2019 at a Price of $6.970.
• [10/21/2019 11:07 PDT] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($6.99) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, September 25th 2019 at a Price of $6.990.
• [10/21/2019 11:07 PDT] Molecular Templates, Inc. (NASDAQ:MTEM), Up By 100.00% ($6.94) After BUYINS.NET SqueezeTrigger Report Released on Monday, September 23rd 2019 at a Price of $6.940.
• [10/21/2019 08:00 PDT] MTEM Expected to Trade Up After Bullish Patterns Develop
• [10/16/2019 07:43 PDT] MTEM Expected to Trade Up Short Term
• [10/15/2019 11:07 PDT] MTEM SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.